Daphne Karydas

Companies

• Compass PathwaysBoard member Sep 20, 2023 to now¹
• Mineralys Therapeutics, Inc.Board member Sep 14, 2023 to now²
• LogicBio Therapeutics, Inc.Board member Dec 14, 2020 to Nov 17, 2022³
• Syndax Pharmaceuticals IncChief financial officer Jul 13, 2020 to Feb 5, 2021⁴
• Eucrates Biomedical Acquisition Corp.Board member Oct 23, 2020 to Oct 23, 2020⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• MTMineralys Therapeutics, Inc. MLYS6,200 shares⁶$134.2K at $21.64Sep 15, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 15, 2026Sold 3,000 shares at $28.58 of Mineralys Therapeutics, Inc.⁶
• Sep 15, 2026Exercised options 3,000 shares at $12.02 of Mineralys Therapeutics, Inc.⁶
• Jun 17, 2026Sold 3,000 shares at $25.00 of Mineralys Therapeutics, Inc.⁷
• Jun 17, 2026Exercised options 3,000 shares at $12.02 of Mineralys Therapeutics, Inc.⁷
• Mar 31, 2026Sold 3,000 shares at $25.00 of Mineralys Therapeutics, Inc.⁸
• Mar 31, 2026Exercised options 3,000 shares at $12.02 of Mineralys Therapeutics, Inc.⁸
• Feb 19, 2026Granted 6,200 shares of Mineralys Therapeutics, Inc.⁹
• Nov 13, 2025Sold 4,885 shares at $46.36 of Mineralys Therapeutics, Inc.¹⁰
• Nov 13, 2025Sold 10,115 shares at $45.81 of Mineralys Therapeutics, Inc.¹⁰
• Nov 13, 2025Exercised options 15,000 shares at $10.20 of Mineralys Therapeutics, Inc.¹⁰